Asia-Pacific Emerges as Fastest-Growing Bioprocess Containers Market with 26.5% CAGR

(MENAFN- P&S Intelligence) According to the latest market research study published by P&S Intelligence, the bioprocess containers market, valued at USD 6.9 billion in 2024, is on a remarkable growth trajectory, projected to expand at a CAGR of 24.5% from 2025 to 2032, reaching USD 39.4 billion by 2032. This unprecedented surge is being powered by the global boom in biologics, including monoclonal antibodies, mRNA vaccines, and advanced cell and gene therapies.

With their superior aseptic conditions, affordability, and operational efficiency, bioprocess containers are rapidly replacing traditional systems. They eliminate the need for time-intensive disinfection and certification processes, making them ideal for fast-track bioproduction facilities. Notably, leading regulatory bodies such as the FDA and EMA actively support the adoption of single-use container systems, recognizing their role in enhancing safety, compliance, and efficiency.

Key Market Trends Transforming the Industry

• Advanced Materials & Smart Designs: Innovations such as high-barrier polymer films, 3D biocontainers capable of handling 5,000 liters, and smart monitoring systems with RFID tagging are redefining scalability, sterility, and regulatory compliance.

• Rapid Facility Deployment: Governments are investing heavily in pandemic preparedness and biologics infrastructure, from the U.S.’s USD 2-billion biomanufacturing initiative to Canada’s CAD 2.2-billion strategy. Disposable systems are now central to modular, plug-and-play cleanrooms and rapid global vaccine production.

• Rising Global Demand for Biologics: With biologics sales forecast to surge from USD 448.1 billion in 2023 to USD 745.1 billion by 2030, the need for flexible, high-volume, and scalable container systems has never been greater.

Market Segmentation Highlights

• By Product:

o 2D Containers dominate with 45% share in 2024, thanks to affordability and broad applicability.
o 3D Containers will record the fastest CAGR (~25%), driven by personalized therapies and large-scale biologics production.

•By Capacity:

o Large Volume Containers (up to 10,000 liters) lead with 85% share.
o Small Volume Containers will grow faster, fueled by demand in R&D and clinical testing.

• By Application:
o Upstream processes account for 50% share, while downstream processes will witness the fastest CAGR (~25.5%).

• By End User:
o Pharma & Biopharma companies remain the largest consumers (55% share).
o CROs & CMOs will grow the fastest, reflecting the industry’s shift toward flexible outsourcing.

Regional Outlook

• North America leads the global market (40% share in 2024), propelled by advanced R&D and FDA-backed adoption of single-use systems.

• Asia-Pacific is set to be the fastest-growing region (CAGR 26.5%), thanks to pro-industry policies in China, India, and South Korea, as well as rising biosimilar demand and cost-effective biomanufacturing.

Competitive Landscape

The market is moderately fragmented, with global leaders like Thermo Fisher Scientific, Cytiva, Sartorius AG, Merck KGaA, and Lonza Group AG driving innovation, alongside specialized regional players delivering niche solutions.

Recent industry moves highlight strong momentum:

• Regeneron & Fujifilm Diosynth Biotechnologies sealed a USD 3-billion, 10-year CDMO deal in April 2025.
• Sartorius AG acquired kSep Systems in 2024 to boost downstream capabilities.
• Merck KGaA launched Ultimus single-use film in 2023, advancing durability and leak protection.

MENAFN15092025005304011875ID1110061230